Covid-19 roundup: US ne­go­ti­at­ing for more dos­es of Pfiz­er vac­cine; Brazil de­lays ef­fi­ca­cy read­out for Sino­vac vac­cine

Af­ter al­leged­ly pass­ing up an of­fer to ac­quire more dos­es of Pfiz­er and BioN­Tech’s Covid-19 vac­cine last month, the US gov­ern­ment is in ne­go­ti­a­tions to dou­ble their dose or­der by next year.

CEO Al­bert Bourla told CN­BC’s “Squawk Box” on Mon­day that the gov­ern­ment is look­ing for 100 mil­lion ad­di­tion­al dos­es — which could vac­ci­nate 50 mil­lion more peo­ple — in Q2 of 2021. The par­ties haven’t signed an agree­ment yet, but Bourla said Pfiz­er would try to make it hap­pen. How­ev­er, some may not come un­til Q3, he said.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER